GLPG0187

GLPG0187 is a broad spectrum integrin receptor antagonist with antitumor activity; inhibits αvβ1-integrin with an IC50 of 1.3 nM. GLPG0187 inhibits migrasome biogenesis without cytotoxicity.


Cat. No.: EX-A1730	Purity: >98%

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
100mg	500	In-stock
250mg	800	In-stock
500mg	1100	In-stock
1g	1885	In-stock
5g	7680	In-stock

Send PO to E-mail:order@excenen.com; or Fax:+86 020 81619670

Discount Request


CAS No.	1320346-97-1
Purity	>98%
Formula	C29H37N7O5S
Mol Weight	595.713
Appearance	Solid powder
Solubility	Soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. van der Horst G, et al. Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer. Neoplasia. 2011 Jun;13(6):516-25. [2]. Puzhong Lu, et al. Chemical screening identifies ROCK1 as a regulator of migrasome formation. Cell Discov. 2020 Aug 4;6(1):51. [3]. Reeves KJ, et al. Prostate cancer cells home to bone using a novel in vivo model: modulation by the integrin antagonist GLPG0187. Int J Cancer. 2015 Apr 1;136(7):1731-40.
CoA	CoA of GLPG0187

Smiles:	COC1=CC=C(C=C1)S(=O)(=O)N[C@@H](CNC1=NC(C)=NC(N2CCC(CC2)C2=NC3=C(CCCN3)C=C2)=C1C)C(O)=O


		Search